by lighthouselab | Jun 7, 2022 | Consulting Services, Industry Insights, RCM Consulting
By: Beth Madden, Client Administrator RCM case study: lazy appeals In reviewing a pathology client’s monthly adjustments report, I noticed there were multiple instances of “appeal denied-adjust per policy” write-offs. Because of the success I had with appeals prior to...
by lighthouselab | May 26, 2022 | Clinical Laboratory, Consulting Services, Industry Insights, RCM Consulting
By: Cassie Penn, Client Manager On October 1, 2021, certain Medicare Advantage Payors, such as UHC, began requiring providers to submit DEX Z-Codes. Other Medicare Advantage Payors may now similarly start utilizing and requiring the use of DEX Z-Codes, according to a...
by lighthouselab | May 20, 2022 | Consulting Services, Industry Insights, RCM Consulting
Ask Ann is a new revenue cycle management mailbag headed by Ann Lambrix, Vice President of RCM Consulting for Lighthouse Lab Services. Each month, Ann will be tackling the burning billing and reimbursement questions from our clinical laboratory and pathology clients....
by lighthouselab | May 4, 2022 | Consulting Services, Industry Insights, RCM Consulting
By: Tracy Augustyniak, Client Manager “Heads or tails?” That’s what goes through my mind when I think about the Federal Independent Dispute Resolution (IDR) Process. The IDR is the process in which an arbitrator decides certain disputes between payors and...
by Alex Mitchell | Apr 19, 2022 | Clinical Laboratory, Consulting Services, Industry Insights, RCM Consulting
Information provided by Tami Shaw, Client Manager, Lighthouse Lab Services Palmetto and WPS have delayed enforcement of the LCD highlighted in this article until May 17, 2022. The LCD will go into effect for CGS and Noridian on June 2, 2022. Laboratories performing...
by lighthouselab | Mar 3, 2022 | Clinical Laboratory, Industry Insights, RCM Consulting
By: Cassie Penn, Client Manager, Lighthouse Lab Services/Vachette As the clinical laboratory advances, we are seeing molecular testing become more available with a wide array of different tests available to physicians and patients. With the increase of molecular...